Showing results (61-70 of 169) with videos related to
Sort By:
Pageof 17
European Journal of Haematology|August 2, 2006
Very high levels of soluble CD30 recognize the patients with classical Hodgkin's lymphoma retaining a very poor prognosisCarlo Visco, Gianpaolo Nadali, Theodoros P Vassilakopoulos, et al.Blood|October 2, 2019
Eltrombopag for immune thrombocytopenia secondary to chronic lymphoproliferative disorders: a phase 2 multicenter studyCarlo Visco, Francesco Rodeghiero, Alessandra Romano, et al.Leukemia & Lymphoma|April 29, 2020
Direct-acting antivirals in relapsed or refractory hepatitis C virus-associated diffuse large B-cell lymphomaMichele Merli, Irene Defrancesco, Carlo Visco, et al.American Journal of Hematology|July 18, 2013
Bendamustine in chronic lymphocytic leukemia: outcome according to different clinical and biological prognostic factors in the everyday clinical practiceFrancesco Zaja, Michael Mian, Stefano Volpetti, et al.British Journal of Haematology|January 4, 2014
Clinical features, management and prognosis of multifocal primary bone lymphoma: a retrospective study of the international extranodal lymphoma study group (the IELSG 14 study)Carlo Messina, Andrés J M Ferreri, Silvia Govi, et al.Hemasphere|April 15, 2022
Outcome of COVID-19 in Patients With Mantle Cell Lymphoma-Report From the European MCL RegistryMarie-Kristin Tilch, Carlo Visco, Sandra Kinda, et al.Scientific Reports|March 20, 2024
B-cell receptor signaling activity identifies patients with mantle cell lymphoma at higher risk of progressionSimona Gambino, Francesca Maria Quaglia, Marilisa Galasso, et al.Hematological Oncology|May 25, 2022
Obinutuzumab does not improve complete methabolic response but does not compromise mobilization or engraftment of autologous peripheral blood stem cells in diffuse large B cell lymphoma: Results from a fondazione italiana linfomi prospective phase II study (the GIOTTO study)Luigi Rigacci, Roberta Battistini, Sofia Kovalchuk, et al.American Journal of Hematology|March 2, 2013
Double productive immunoglobulin sequence rearrangements in patients with chronic lymphocytic leukemiaCarlo Visco, Francesca Moretta, Erika Falisi, et al.Oncotarget|June 19, 2015
Epstein-Barr virus DNA load in chronic lymphocytic leukemia is an independent predictor of clinical course and survivalCarlo Visco, Erika Falisi, Ken H Young, et al.Pageof 17